Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Though low, this figure is three times the rate of discontinuation seen in clinical trials.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
All women who completed follow-up in a small trial were cured, and none of their infants contracted the virus.
Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.
In a recent letter, the politician notes that the VA has stopped enrolling HCV-positive veterans because of budget constraints.
Analysts credit the spark in innovation to the FDA’s new ’Breakthrough Therapy Designation.’
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.